Literature DB >> 19921233

Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma.

Theodoros A Papadas1, Evangelos C Alexopoulos, Antony Mallis, Eleni Jelastopulu, Nicholas S Mastronikolis, Panos Goumas.   

Abstract

Survival trends in survival for laryngeal cancer in Europe are varied. Five-year survival varied around 60-64% but numbers below 50% have been commonly reported. The aim of this study was to assess the factors influencing survival in patients with laryngeal cancer in our region. A total of 128 male and 5 female patients with larynx cancer (91 glottic and 42 supraglottic) were treated at Patras University Hospital between March 1992 and August 2004. Except 3, all were smokers and 56 (41%) heavy alcohol users. Postsurgical staging showed that most had been classified at stages III (38%) and IV (49%). By histology, 31 tumors were classified as poorly differentiated, 78 as moderately differentiated and 23 as well differentiated. All patients underwent laryngectomy with extension of the procedure where appropriate. Also, a total of 45 patients received adjuvant therapy (either chemotherapy or radiotherapy). Farmers, construction workers, professional drivers and mechanics and coffee shop and bar employees account for more than 70% of patients. Results showed that 64 (48.1%) patients died during the follow-up, 58 (43.6%) of them died from cause related to their disease. With a median follow-up of 25 months, the 5-year disease-free survival (DFS) was 53% and the 5-year overall survival (OS) was 45%. Significant prognostic factors for OS included patient age, advanced staging, heavy alcohol use and poor tumor differentiation while for DFS affected mainly by poor tumor differentiation. We conclude that the disease stage at presentation, tumor grade and alcohol consumption prove to be important predictors for the OS as well as the DFS in our series.

Entities:  

Mesh:

Year:  2009        PMID: 19921233     DOI: 10.1007/s00405-009-1156-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

Review 1.  Biological characterization of laryngeal squamous-cell carcinoma.

Authors:  R M Tomasino; V Bazan; E Daniele; R Nuara; V Morello; V Tralongo; G Leto; A Russo
Journal:  Anticancer Res       Date:  1996 Jul-Aug       Impact factor: 2.480

2.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

3.  [An analysis of factor influencing the outcome of patients with locally advanced larynx cancer].

Authors:  Jadwiga Kubrak; Alina Jarema; Michał Falco; Danuta Rogowska; Agnieszka Rubik; Bogdan Torbé
Journal:  Otolaryngol Pol       Date:  2008

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Predictors of local failure in early laryngeal cancer.

Authors:  R Lohynska; A Slavicek; A Bahanan; P Novakova
Journal:  Neoplasma       Date:  2005       Impact factor: 2.575

Review 6.  Current opinion in diagnosis and treatment of laryngeal carcinoma.

Authors:  Gino Marioni; Rosario Marchese-Ragona; Giuseppe Cartei; Fortunata Marchese; Alberto Staffieri
Journal:  Cancer Treat Rev       Date:  2006-08-22       Impact factor: 12.111

7.  Staging and survival analysis for nonsquamous cell carcinomas of the larynx.

Authors:  Harrison W Lin; Neil Bhattacharyya
Journal:  Laryngoscope       Date:  2008-06       Impact factor: 3.325

Review 8.  Alcohol and laryngeal cancer: an update.

Authors:  Carlo La Vecchia; Zuo Feng Zhang; Andrea Altieri
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

Review 9.  Management of T1-T2 glottic carcinomas.

Authors:  William M Mendenhall; John W Werning; Russell W Hinerman; Robert J Amdur; Douglas B Villaret
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

10.  A study of the interaction of alcohol drinking and tobacco smoking among French cases of laryngeal cancer.

Authors:  P Guénel; J F Chastang; D Luce; A Leclerc; J Brugère
Journal:  J Epidemiol Community Health       Date:  1988-12       Impact factor: 3.710

View more
  13 in total

1.  MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47.

Authors:  Hui Li; Yan Wang; Yan-Zhong Li
Journal:  Tumour Biol       Date:  2016-10-11

2.  Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.

Authors:  Kunpeng Ma; Limin Ma; Zhaocheng Jian
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

3.  Analysis of multicentricity in supraglottic laryngeal carcinoma treated with partial laryngeal surgery.

Authors:  Ela Cömert; Umit Tunçel; Ziya Sencan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-30       Impact factor: 2.503

4.  Development of a time-dependent numerical model for the assessment of non-stationary pharyngoesophageal tissue vibrations after total laryngectomy.

Authors:  Björn Hüttner; Georg Luegmair; Rita R Patel; Anke Ziethe; Ulrich Eysholdt; Christopher Bohr; Irina Sebova; Marion Semmler; Michael Döllinger
Journal:  Biomech Model Mechanobiol       Date:  2014-05-27

5.  Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy.

Authors:  Qiong Yu; Xueyuan Zhang; Changyou Ji; Hua Yang; Minghua Gao; Suling Hong; Guohua Hu
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-21       Impact factor: 2.503

6.  Expression, purification, and evaluation for anticancer activity of ribosomal protein L31 gene (RPL31) from the giant panda (Ailuropoda melanoleuca).

Authors:  Xiu-Lan Su; Yi-Ling Hou; Xiang-Hui Yan; Xiang Ding; Wan-Ru Hou; Bing Sun; Si-Nan Zhang
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

7.  MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.

Authors:  Kemin Cai; Yu Wang; Xueli Bao
Journal:  J Exp Clin Cancer Res       Date:  2011-08-08

8.  Clinical Significance of miR-149 in the Survival of Patients with Laryngeal Squamous Cell Carcinoma.

Authors:  Yi Xu; Yun-Peng Lin; Dong Yang; Geng Zhang; Hui-Fang Zhou
Journal:  Biomed Res Int       Date:  2016-06-15       Impact factor: 3.411

9.  High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis.

Authors:  Wei Zhang; Yongbing Yan; Miao Gu; Xudong Wang; Huijun Zhu; Shu Zhang; Wei Wang
Journal:  Oncol Lett       Date:  2017-06-15       Impact factor: 2.967

10.  Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Xiao-Ning Luo; Liang-Si Chen; Ping-Jiang Ge; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.